Home Healthcare Biotechnology Neoantigen Cancer Vaccine Market

Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalised neo-antigen vaccine, Off-the-shelf neoantigen vaccine), By Neoantigen Type (Synthetic Long Peptide, Nucleic acid, Dendritic cell, Tumour cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA Sequencing, Whole Genome Sequencing, HLA Typing), By Delivery Mechanism (Liposomes, Virosomes, Gene gun, Electroporation, Others), By Application (Lung, Melanoma, Gastrointestinal, Brain cancer, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR1920DR | Pages: 154
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Neoantigen Cancer Vaccine Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Personalised neo-antigen vaccine
    2. Off-the-shelf neoantigen vaccine
  2. Neoantigen Cancer Vaccine Market, By Neoantigen Type 2022-2034 (USD MILLION/ Units)
    1. Synthetic Long Peptide
    2. Nucleic acid
    3. Dendritic cell
    4. Tumour cell
  3. Neoantigen Cancer Vaccine Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Intravenous
    2. Intramuscular
    3. Transdermal
    4. Others
  4. Neoantigen Cancer Vaccine Market, By Cell 2022-2034 (USD MILLION/ Units)
    1. Autologous
    2. Allogenic
  5. Neoantigen Cancer Vaccine Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. RNA Sequencing
    2. Whole Genome Sequencing
    3. HLA Typing
  6. Neoantigen Cancer Vaccine Market, By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
    1. Liposomes
    2. Virosomes
    3. Gene gun
    4. Electroporation
    5. Others
  7. Neoantigen Cancer Vaccine Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Lung
    2. Melanoma
    3. Gastrointestinal
    4. Brain cancer
    5. Others
  8. Regional Neoantigen Cancer Vaccine Market
    1. North America
      1. North America Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      2. North America Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      3. North America Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      4. North America Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      5. North America Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      6. North America Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      7. North America Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
      8. U.S. Neoantigen Cancer Vaccine Market
        1. U.S. Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. U.S. Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. U.S. Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. U.S. Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. U.S. Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. U.S. Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. U.S. Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      9. Canada Neoantigen Cancer Vaccine Market
        1. Canada Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Canada Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Canada Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Canada Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Canada Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Canada Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Canada Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
    2. Europe
      1. Europe Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      2. Europe Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      3. Europe Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      4. Europe Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      5. Europe Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      6. Europe Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      7. Europe Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
      8. U.K. Neoantigen Cancer Vaccine Market
        1. U.K. Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. U.K. Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. U.K. Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. U.K. Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. U.K. Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. U.K. Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. U.K. Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      9. Germany Neoantigen Cancer Vaccine Market
        1. Germany Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Germany Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Germany Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Germany Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Germany Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Germany Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Germany Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      10. France Neoantigen Cancer Vaccine Market
        1. France Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. France Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. France Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. France Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. France Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. France Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. France Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      11. Spain Neoantigen Cancer Vaccine Market
        1. Spain Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Spain Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Spain Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Spain Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Spain Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Spain Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Spain Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      12. Italy Neoantigen Cancer Vaccine Market
        1. Italy Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Italy Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Italy Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Italy Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Italy Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Italy Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Italy Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      13. Russia Neoantigen Cancer Vaccine Market
        1. Russia Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Russia Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Russia Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Russia Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Russia Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Russia Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Russia Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      14. Nordic Neoantigen Cancer Vaccine Market
        1. Nordic Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Nordic Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Nordic Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Nordic Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Nordic Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Nordic Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Nordic Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      15. Benelux Neoantigen Cancer Vaccine Market
        1. Benelux Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Benelux Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Benelux Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Benelux Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Benelux Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Benelux Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Benelux Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      16. Rest of Europe Neoantigen Cancer Vaccine Market
        1. Rest of Europe Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Rest of Europe Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Rest of Europe Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Rest of Europe Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Rest of Europe Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Rest of Europe Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Rest of Europe Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
    3. APAC
      1. APAC Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      2. APAC Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      3. APAC Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      4. APAC Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      5. APAC Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      6. APAC Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      7. APAC Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
      8. China Neoantigen Cancer Vaccine Market
        1. China Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. China Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. China Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. China Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. China Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. China Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. China Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      9. Korea Neoantigen Cancer Vaccine Market
        1. Korea Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Korea Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Korea Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Korea Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Korea Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Korea Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Korea Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      10. Japan Neoantigen Cancer Vaccine Market
        1. Japan Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Japan Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Japan Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Japan Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Japan Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Japan Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Japan Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      11. India Neoantigen Cancer Vaccine Market
        1. India Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. India Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. India Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. India Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. India Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. India Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. India Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      12. Australia Neoantigen Cancer Vaccine Market
        1. Australia Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Australia Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Australia Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Australia Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Australia Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Australia Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Australia Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      13. Taiwan Neoantigen Cancer Vaccine Market
        1. Taiwan Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Taiwan Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Taiwan Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Taiwan Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Taiwan Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Taiwan Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Taiwan Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      14. South East Asia Neoantigen Cancer Vaccine Market
        1. South East Asia Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. South East Asia Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. South East Asia Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. South East Asia Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. South East Asia Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. South East Asia Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. South East Asia Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      15. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market
        1. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Rest of Asia-Pacific Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
    4. Middle East and Africa
      1. Middle East and Africa Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      2. Middle East and Africa Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      3. Middle East and Africa Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      4. Middle East and Africa Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      5. Middle East and Africa Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      6. Middle East and Africa Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      7. Middle East and Africa Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
      8. UAE Neoantigen Cancer Vaccine Market
        1. UAE Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. UAE Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. UAE Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. UAE Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. UAE Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. UAE Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. UAE Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      9. Turkey Neoantigen Cancer Vaccine Market
        1. Turkey Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Turkey Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Turkey Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Turkey Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Turkey Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Turkey Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Turkey Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      10. Saudi Arabia Neoantigen Cancer Vaccine Market
        1. Saudi Arabia Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Saudi Arabia Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Saudi Arabia Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Saudi Arabia Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Saudi Arabia Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Saudi Arabia Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Saudi Arabia Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      11. South Africa Neoantigen Cancer Vaccine Market
        1. South Africa Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. South Africa Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. South Africa Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. South Africa Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. South Africa Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. South Africa Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. South Africa Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      12. Egypt Neoantigen Cancer Vaccine Market
        1. Egypt Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Egypt Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Egypt Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Egypt Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Egypt Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Egypt Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Egypt Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      13. Nigeria Neoantigen Cancer Vaccine Market
        1. Nigeria Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Nigeria Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Nigeria Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Nigeria Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Nigeria Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Nigeria Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Nigeria Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      14. Rest of MEA Neoantigen Cancer Vaccine Market
        1. Rest of MEA Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Rest of MEA Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Rest of MEA Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Rest of MEA Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Rest of MEA Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Rest of MEA Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Rest of MEA Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
    5. LATAM
      1. LATAM Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Personalised neo-antigen vaccine
        2. Off-the-shelf neoantigen vaccine
      2. LATAM Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
        1. Synthetic Long Peptide
        2. Nucleic acid
        3. Dendritic cell
        4. Tumour cell
      3. LATAM Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Intramuscular
        3. Transdermal
        4. Others
      4. LATAM Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
        1. Autologous
        2. Allogenic
      5. LATAM Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Sequencing
        2. Whole Genome Sequencing
        3. HLA Typing
      6. LATAM Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Virosomes
        3. Gene gun
        4. Electroporation
        5. Others
      7. LATAM Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
        1. Lung
        2. Melanoma
        3. Gastrointestinal
        4. Brain cancer
        5. Others
      8. Brazil Neoantigen Cancer Vaccine Market
        1. Brazil Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Brazil Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Brazil Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Brazil Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Brazil Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Brazil Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Brazil Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      9. Mexico Neoantigen Cancer Vaccine Market
        1. Mexico Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Mexico Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Mexico Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Mexico Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Mexico Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Mexico Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Mexico Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      10. Argentina Neoantigen Cancer Vaccine Market
        1. Argentina Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Argentina Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Argentina Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Argentina Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Argentina Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Argentina Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Argentina Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      11. Chile Neoantigen Cancer Vaccine Market
        1. Chile Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Chile Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Chile Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Chile Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Chile Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Chile Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Chile Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      12. Colombia Neoantigen Cancer Vaccine Market
        1. Colombia Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Colombia Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Colombia Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Colombia Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Colombia Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Colombia Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Colombia Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
      13. Rest of LATAM Neoantigen Cancer Vaccine Market
        1. Rest of LATAM Neoantigen Cancer Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
          1. Personalised neo-antigen vaccine
          2. Off-the-shelf neoantigen vaccine
        2. Rest of LATAM Neoantigen Cancer Vaccine Market By Neoantigen Type 2022-2034 (USD MILLION/ Units)
          1. Synthetic Long Peptide
          2. Nucleic acid
          3. Dendritic cell
          4. Tumour cell
        3. Rest of LATAM Neoantigen Cancer Vaccine Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Intravenous
          2. Intramuscular
          3. Transdermal
          4. Others
        4. Rest of LATAM Neoantigen Cancer Vaccine Market By Cell 2022-2034 (USD MILLION/ Units)
          1. Autologous
          2. Allogenic
        5. Rest of LATAM Neoantigen Cancer Vaccine Market By Technology 2022-2034 (USD MILLION/ Units)
          1. RNA Sequencing
          2. Whole Genome Sequencing
          3. HLA Typing
        6. Rest of LATAM Neoantigen Cancer Vaccine Market By Delivery Mechanism 2022-2034 (USD MILLION/ Units)
          1. Liposomes
          2. Virosomes
          3. Gene gun
          4. Electroporation
          5. Others
        7. Rest of LATAM Neoantigen Cancer Vaccine Market By Application 2022-2034 (USD MILLION/ Units)
          1. Lung
          2. Melanoma
          3. Gastrointestinal
          4. Brain cancer
          5. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.